123 related articles for article (PubMed ID: 3473620)
1. Lymphoproliferative disorders in Japanese patients with Sjögren's syndrome.
Sugai S; Shimizu S; Konda S
Scand J Rheumatol Suppl; 1986; 61():118-22. PubMed ID: 3473620
[TBL] [Abstract][Full Text] [Related]
2. B-cell malignancy and monoclonal gammopathy, and idiotype of cell surface and serum immunoglobulin.
Sugai S; Takiguchi T; Hirose Y; Konaka Y; Shimizu S; Konda S
Jpn J Clin Oncol; 1983 Sep; 13(3):533-42. PubMed ID: 6417376
[TBL] [Abstract][Full Text] [Related]
3. Monoclonal gammopathies in patients with Sjögren's syndrome.
Sugai S; Shimizu S; Tachibana J; Sawada M; Hirose Y; Takiguchi T; Konda S
Jpn J Med; 1988 Feb; 27(1):2-9. PubMed ID: 3285062
[TBL] [Abstract][Full Text] [Related]
4. Salivary gland lymphomas in patients with Sjögren's syndrome may frequently develop from rheumatoid factor B cells.
Martin T; Weber JC; Levallois H; Labouret N; Soley A; Koenig S; Korganow AS; Pasquali JL
Arthritis Rheum; 2000 Apr; 43(4):908-16. PubMed ID: 10765938
[TBL] [Abstract][Full Text] [Related]
5. Non-Hodgkin's lymphoma associated with primary Sjögren's syndrome.
Pariente D; Anaya JM; Combe B; Jorgensen C; Emberger JM; Rossi JF; Sany J
Eur J Med; 1992 Oct; 1(6):337-42. PubMed ID: 1341461
[TBL] [Abstract][Full Text] [Related]
6. [Lymphoproliferative disorders in patients with Sjögren's syndrome--Vg gene rearrangement and expression of bcl-2 protein].
Sugai S; Takeshita S; Ogawa Y; Masaki Y; Doumiki T; Takeuchi Y
Nihon Rinsho; 1995 Oct; 53(10):2580-6. PubMed ID: 8531377
[TBL] [Abstract][Full Text] [Related]
7. Sjögren's syndrome in patients with newly diagnosed untreated non-Hodgkin's lymphoma.
Andonopoulos AP; Tiniakou M; Melachrinou M; Sfountouris H; Bounas A; Zervas C; Zoumbos NC
Rev Rhum Engl Ed; 1997 May; 64(5):287-92. PubMed ID: 9190001
[TBL] [Abstract][Full Text] [Related]
8. [Breast cancer and B cell malignant lymphoma associated with Sjögren'ssyndrome--a case report and review of literature in Japan].
Kohno A; Kohriyama K; Arimori S
Ryumachi; 1990 Oct; 30(5):388-93, 395; discussion 393-4. PubMed ID: 2084862
[TBL] [Abstract][Full Text] [Related]
9. [Lymphoproliferative diseases and paraproteinemias in Sjogren's syndrome].
Bolognini G; Riva G
Schweiz Med Wochenschr; 1975 Nov; 105(45):1493-505. PubMed ID: 1215941
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis C virus infection, Sjögren's syndrome, and non-Hodgkin's lymphoma.
Selva-O'Callaghan A; Rodriguez-Pardo D; Sanchez-Sitjes L; Matas-Pericas L; Solans-Laque R; Bosch-Gil JA; Vilardell-Tarrés M
Arthritis Rheum; 1999 Nov; 42(11):2489-90. PubMed ID: 10555045
[No Abstract] [Full Text] [Related]
11. Association between primary Sjögren's syndrome and non-Hodgkin's lymphoma.
Opriş D; Iosif CI; Predeţeanu D
Rom J Intern Med; 2004; 42(4):715-23. PubMed ID: 16366143
[TBL] [Abstract][Full Text] [Related]
12. Minor salivary gland immunohistology in the diagnosis of primary Sjögren's syndrome.
Salomonsson S; Rozell BL; Heimburger M; Wahren-Herlenius M
J Oral Pathol Med; 2009 Mar; 38(3):282-8. PubMed ID: 18793250
[TBL] [Abstract][Full Text] [Related]
13. Long-term risk of mortality and lymphoproliferative disease and predictive classification of primary Sjögren's syndrome.
Ioannidis JP; Vassiliou VA; Moutsopoulos HM
Arthritis Rheum; 2002 Mar; 46(3):741-7. PubMed ID: 11920410
[TBL] [Abstract][Full Text] [Related]
14. [Mixed cryoglobulinaemia and benign monoclonal gammopathy in Sjogren's syndrome (author's transl)].
Clerc D; Segond P; Sallière D; Margulis J; Bisson M; Massias P
Sem Hop; 1980 Sep 8-15; 56(29-32):1290-2. PubMed ID: 6252617
[TBL] [Abstract][Full Text] [Related]
15. Differential risk of non-Hodgkin's lymphoma in Italian patients with primary Sjögren's syndrome.
Valesini G; Priori R; Bavoillot D; Osborn J; Danieli MG; Del Papa N; Gerli R; Pietrogrande M; Sabbadini MG; Silvestris F; Valsecchi L
J Rheumatol; 1997 Dec; 24(12):2376-80. PubMed ID: 9415645
[TBL] [Abstract][Full Text] [Related]
16. IgA and IgG autoantibodies against alpha-fodrin as markers for Sjögren's syndrome. Systemic lupus erythematosus.
Witte T; Matthias T; Arnett FC; Peter HH; Hartung K; Sachse C; Wigand R; Braner A; Kalden JR; Lakomek HJ; Schmidt RE
J Rheumatol; 2000 Nov; 27(11):2617-20. PubMed ID: 11093442
[TBL] [Abstract][Full Text] [Related]
17. Lymphoma in Sjögren's syndrome: urinary monoclonal free light chains as a diagnostic aid and a means of tumour monitoring.
Walters MT; Stevenson FK; Herbert A; Cawley MI; Smith JL
Scand J Rheumatol Suppl; 1986; 61():114-7. PubMed ID: 3109020
[TBL] [Abstract][Full Text] [Related]
18. Long term remission of Sjögren's syndrome associated aggressive B cell non-Hodgkin's lymphomas following combined B cell depletion therapy and CHOP (cyclophosphamide, doxorubicin, vincristine, prednisone).
Voulgarelis M; Giannouli S; Tzioufas AG; Moutsopoulos HM
Ann Rheum Dis; 2006 Aug; 65(8):1033-7. PubMed ID: 16322082
[TBL] [Abstract][Full Text] [Related]
19. A high incidence of rheumatoid factor idiotypes in monoclonal proteins in the serum and in lymphoma cells in patients with Sjögren's syndrome.
Sugai S; Shimizu S; Tachibana J; Imaoka S; Konda S
J Autoimmun; 1989 Aug; 2(4):471-6. PubMed ID: 2506879
[TBL] [Abstract][Full Text] [Related]
20. Salivary gland B cell lymphoproliferative disorders in Sjögren's syndrome present a restricted use of antigen receptor gene segments similar to those used by hepatitis C virus-associated non-Hodgkins's lymphomas.
De Re V; De Vita S; Gasparotto D; Marzotto A; Carbone A; Ferraccioli G; Boiocchi M
Eur J Immunol; 2002 Mar; 32(3):903-10. PubMed ID: 11870635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
